Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G THURSTON

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Journal of the National Cancer Institute|February 1, 1980
Specificity of heteroantisera developed against purified populations of intact murine ovarian carcinoma cellsR C Bast, R C Knapp, V C Donahue, et al.
Oncogene|June 28, 2016
FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signalingC Daly, C Castanaro, W Zhang, et al.
The American Journal of Physiology|July 1, 1997
Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in miceJ W McLean, E A Fox, P Baluk, et al.
The Journal of Biological Chemistry|April 25, 1990
A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectinM Clauss, J C Murray, M Vianna, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 24, 2005
Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survivalRiad Salem, Robert J Lewandowski, Bassel Atassi, et al.
Nature Medicine|March 31, 2000
Angiopoietin-1 protects the adult vasculature against plasma leakageG Thurston, J S Rudge, E Ioffe, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 24, 2005
90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imagingRobert J Lewandowski, Kenneth G Thurston, James E Goin, et al.
Gastroenterology|October 28, 2004
Yttrium-90 microspheres for the treatment of hepatocellular carcinomaJean Francois H Geschwind, Riad Salem, Brian I Carr, et al.
The EMBO Journal|March 17, 2001
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic miceT Veikkola, L Jussila, T Makinen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 1999
Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivoM Corada, M Mariotti, G Thurston, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Journal of the National Cancer Institute|February 1, 1980
Specificity of heteroantisera developed against purified populations of intact murine ovarian carcinoma cellsR C Bast, R C Knapp, V C Donahue, et al.
Oncogene|June 28, 2016
FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signalingC Daly, C Castanaro, W Zhang, et al.
The American Journal of Physiology|July 1, 1997
Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in miceJ W McLean, E A Fox, P Baluk, et al.
The Journal of Biological Chemistry|April 25, 1990
A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectinM Clauss, J C Murray, M Vianna, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 24, 2005
Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survivalRiad Salem, Robert J Lewandowski, Bassel Atassi, et al.
Nature Medicine|March 31, 2000
Angiopoietin-1 protects the adult vasculature against plasma leakageG Thurston, J S Rudge, E Ioffe, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 24, 2005
90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imagingRobert J Lewandowski, Kenneth G Thurston, James E Goin, et al.
Gastroenterology|October 28, 2004
Yttrium-90 microspheres for the treatment of hepatocellular carcinomaJean Francois H Geschwind, Riad Salem, Brian I Carr, et al.
The EMBO Journal|March 17, 2001
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic miceT Veikkola, L Jussila, T Makinen, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 18, 1999
Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivoM Corada, M Mariotti, G Thurston, et al.
Pageof 11